Research and Markets: Hepatocellular Carcinoma - Pipeline Review, H1 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9lkw28/hepatocellular) has announced the addition of the "Hepatocellular Carcinoma - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Hepatocellular Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatocellular Carcinoma and special features on late-stage and discontinued projects.

This report features investigational drugs from across the globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergo periodic update following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Mentioned

Partial list of the 100+ companies featured in this report:

  • 4SC AG
  • Acceleron Pharma
  • Bayer
  • Bio-Cancer Treatment International
  • Caladrius Biosciences
  • Can-Fite BioPharma
  • Delcath Systems
  • Dicerna Pharmaceuticals
  • Eisai
  • F. Hoffmann-La Roche
  • Gamida Cell
  • Immune Network
  • Immunicum
  • Johnson & Johnson
  • KAHR medical
  • Ligand Pharmaceuticals,
  • Lixte Biotechnology Holdings
  • MaxCyte
  • Nerviano Medical Sciences
  • Nimbus Therapeutics
  • Omeros Corporation
  • Panacea Pharmaceuticals
  • Raptor Pharmaceuticals
  • Shenogen Pharma
  • Taiwan Liposome
  • VasGene Therapeutics

For more information visit http://www.researchandmarkets.com/research/9lkw28/hepatocellular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology